comparemela.com

Latest Breaking News On - Augmedix daily - Page 1 : comparemela.com

Millrace Asset Group Inc Has $1 19 Million Position in Augmedix, Inc (NASDAQ:AUGX)

Millrace Asset Group Inc. decreased its holdings in shares of Augmedix, Inc. (NASDAQ:AUGX – Free Report) by 40.1% in the 4th quarter, HoldingsChannel reports. The firm owned 203,087 shares of the company’s stock after selling 135,745 shares during the period. Millrace Asset Group Inc.’s holdings in Augmedix were worth $1,188,000 as of its most recent […]

Augmedix, Inc (NASDAQ:AUGX) Stock Position Reduced by Millrace Asset Group Inc

Millrace Asset Group Inc. trimmed its position in Augmedix, Inc. (NASDAQ:AUGX – Free Report) by 40.1% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 203,087 shares of the company’s stock after selling 135,745 shares during the quarter. Millrace Asset Group Inc. owned approximately […]

Comparing Augmedix (NASDAQ:AUGX) and Micromobility com (NASDAQ:MCOM)

Augmedix (NASDAQ:AUGX – Get Free Report) and Micromobility.com (NASDAQ:MCOM – Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, risk, profitability, dividends, valuation, institutional ownership and earnings. Volatility and Risk Augmedix has a beta of 0.03, […]

Augmedix (NASDAQ:AUGX) Downgraded by Evercore ISI

Evercore ISI lowered shares of Augmedix (NASDAQ:AUGX – Free Report) from an outperform rating to an inline rating in a report issued on Tuesday, MarketBeat reports. They currently have $1.50 price objective on the stock, down from their prior price objective of $5.00. Other research analysts also recently issued reports about the stock. Maxim Group […]

Augmedix (NASDAQ:AUGX) Rating Lowered to Hold at Maxim Group

Maxim Group lowered shares of Augmedix (NASDAQ:AUGX – Free Report) from a buy rating to a hold rating in a report issued on Tuesday, Marketbeat Ratings reports. The brokerage currently has $5.00 target price on the stock. A number of other equities analysts also recently commented on AUGX. B. Riley started coverage on shares of […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.